abstract |
FIELD: chemistry. n SUBSTANCE: described are novel compounds of general formula (I) n , where the value of each symbol is defined in the claim, which are ORL-1 receptor agonists. n EFFECT: improved bioavailability, based on improved metabolic stability, strong and high selectivity and can be used in medicine. n 7 cl, 148 ex, 35 tbl |